PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index.
Casazza A, Van Helleputte L, Van Renterghem B, Pokreisz P, De Geest N, De Petrini M, Janssens T, Pellens M, Diricx M, Riera-Domingo C, Wozniak A, Mazzone M, Schöffski P, Defert O, Reyns G, Kindt N.
Casazza A, et al. Among authors: van renterghem b.
Mol Cancer Ther. 2022 Apr 1;21(4):568-581. doi: 10.1158/1535-7163.MCT-21-0518.
Mol Cancer Ther. 2022.
PMID: 35149549
Free PMC article.